SBC Medical Group Holdings stock analysis
Want to see SBC full AI Analyst Report?
SBC Medical Group Holdings (SBC) Stock Price & Analysis
SBC Stock Chart & Stats
- Day’s Range
- $5.75 - $6.29
- 52-Week Range
- $2.78 - $7.39
- Previous Close
- $6.18
- Volume
- N/A
- Average Volume (3M)
- 283.60K
- Market Cap
- $635.59M
- Enterprise Value
- $364.66M
- Total Cash (Recent Filing)
- $202.75M
- Total Debt (Recent Filing)
- $44.05M
- Price to Earnings (P/E)
- 12.6
- Beta
- 0.71
- Next Earnings
- Mar 26, 2027 (Est.)
- EPS Estimate
- 0.12
- Next Dividend Ex-Date
- N/A
- Dividend Yield
- N/A
Bulls Say, Bears Say
Bulls Say
High Profitability And Cash Generation
SBC combines strong operating margins with free cash flow that roughly matches net income, supporting earnings quality. This internally generated cash can fund clinic openings, acquisitions, technology, and other strategic initiatives while reducing reliance on external financing.
Clinic Network Expansion
A growing clinic network expands SBC’s addressable customer base and increases the platform available for management, rental, and service-fee revenue. Continued openings and M&A could reinforce scale advantages and extend the company’s position across multiple medical categories.
Strong Same-clinic Demand And Pricing
Growth in visits, customers, and average spend indicates that performance is supported by both demand and monetization, not only by adding locations. This combination can improve clinic productivity and provide a durable foundation for service-fee growth and operating leverage.
Bears Say
Governance And Ownership Concentration
High insider ownership can align management with long-term outcomes but also concentrates voting power and may limit minority-holder influence. The continuing shortage of independent directors adds oversight risk and could affect investor confidence, accountability, and future capital-allocation decisions.
Intense Competitive Pressure In Japan
Clinic closures and difficulty sustaining the pricing environment show that competition can pressure affiliated providers and limit the durability of growth. If pricing or customer acquisition becomes harder, SBC may face weaker clinic productivity, slower expansion, or pressure on service-fee economics.
Historically Volatile Cash Conversion
The strong TTM cash rebound is encouraging, but prior negative operating and free cash flow demonstrates that cash generation has not been consistently predictable. Recurring volatility could constrain internally funded expansion and make results more sensitive to operating changes or investment requirements.
SBC Medical Group Holdings News
SBC Medical enters capital, business alliance agreement with AtomicSoftware
SBC Medical Group (SBC) announced that it entered into a capital and business alliance agreement on October 26, 2026, with AtomicSoftware, the Tokyo-based provider of medicalforce, an all-in-one software-as-a-service platform
SBC FAQ
What was SBC Medical Group Holdings’s price range in the past 12 months?
What is SBC Medical Group Holdings’s market cap?
When is SBC Medical Group Holdings’s upcoming earnings report date?
How were SBC Medical Group Holdings’s earnings last quarter?
Is SBC Medical Group Holdings overvalued?
Does SBC Medical Group Holdings pay dividends?
What is SBC Medical Group Holdings’s EPS estimate?
How many shares outstanding does SBC Medical Group Holdings have?
What happened to SBC Medical Group Holdings’s price movement after its last earnings report?
Which hedge fund is a major shareholder of SBC Medical Group Holdings?
What is the TipRanks Smart Score and how is it calculated?
SBC Medical Group Holdings Stock Smart Score
Company Description
SBC Medical Group Holdings
SBC Medical Group Holdings Incorporated provides comprehensive operational support to aesthetic and cosmetic clinics across a global footprint, including Japan, Vietnam, the United States, and other international markets. The company delivers a diverse array of administrative and support functions, such as orchestrating marketing and advertising campaigns, offering extensive human resources solutions including talent acquisition and staff training, and streamlining appointment scheduling for franchisee clinics. Furthermore, SBC Medical Group facilitates real estate arrangements for both employee housing and clinic facility rentals, oversees the design and construction of new clinics, and manages the procurement of essential medical equipment and supplies. Additionally, the firm furnishes IT software solutions. The broad spectrum of aesthetic and reconstructive procedures facilitated by SBC Medical Group's supported clinics encompasses both surgical and non-surgical interventions. These include popular treatments such as breast augmentation, liposuction, and various rejuvenation therapies targeting wrinkles, acne, scars, and signs of aging. The offerings also extend to specialized procedures like laser skin toning, double fold eye surgery, rhinoplasty, hair transplants, laser hair removal, cosmetic dental work, tattoo removal, and advanced eye procedures like LASIK, among others. Established in 2000, SBC Medical Group Holdings Incorporated maintains its headquarters in Irvine, California.
- Sector
- Industrials
- Industry
- Consulting Services
- CEO
- Yoshiyuki Aikawa
- Employees
- 863
- Website
- sbc-holdings.com
- Address
- 200 Spectrum Center Drive, Irvine, CA, 92618, US
SBC Medical Group Holdings (SBC) Earnings & Revenues
SBC Company Deck
SBC Earnings Call
Earnings Call SentimentPositive
The call was strongly positive, led by 35% revenue growth, 66% growth in operating income and adjusted EBITDA, a 47% adjusted EBITDA margin, healthy same-clinic trends, continued network expansion, and several AI, longevity, and international growth initiatives. The main concerns were ongoing governance issues, intense competition in Japan, limited near-term longevity revenue, room for greater U.S. capital-market recognition, and the decision not to pursue an additional share buyback at present.
View all SBC earnings summariesSBC Stock 12 Month Forecast
Average Price Target
Technical Analysis
Overall Consensus
| Indicator | Bullish | Neutral | Bearish |
|---|---|---|---|
| Overall Consensus | 15 | 5 | 2 |
| Technical Analysis | 3 | 5 | 2 |
| Moving Averages | 12 | 0 | 0 |










